BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12871367)

  • 1. Long-lasting antithrombotic effects of a single dose of human recombinant, active site-blocked factor VII: insights into possible mechanism(s) of action.
    Cirillo P; Golino P; Ragni M; D'andrea D; Calabró P; Corcione N; Vigorito F; Ravera M; Chiariello M
    J Thromb Haemost; 2003 May; 1(5):992-8. PubMed ID: 12871367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
    Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M
    Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction.
    Golino P; Ragni M; Cirillo P; D'Andrea D; Ravera M; Calabro P; Ezban M; Tommasini P; Chiariello M
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S149-58. PubMed ID: 10850582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.
    Rao LV; Ezban M
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S135-43. PubMed ID: 10850580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
    Kouz J; Czech J; Nicolay U; Dickneite G
    Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis.
    Arnljots B; Söderström T; Ezban M; Hedner U
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S145-8. PubMed ID: 10850581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.
    Pawashe AB; Golino P; Ambrosio G; Migliaccio F; Ragni M; Pascucci I; Chiariello M; Bach R; Garen A; Konigsberg WK
    Circ Res; 1994 Jan; 74(1):56-63. PubMed ID: 8261595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
    Söderström T; Hedner U; Arnljots B
    J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.
    Chi L; Gibson G; Peng YW; Bousley R; Brammer D; Rekhter M; Chen J; Leadley R
    J Thromb Haemost; 2004 Jan; 2(1):85-92. PubMed ID: 14717971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
    Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
    Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.
    Golino P; Ragni M; Cirillo P; Scognamiglio A; Ravera A; Buono C; Guarino A; Piro O; Lambiase C; Botticella F; Ezban M; Condorelli M; Chiariello M
    Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1507-16. PubMed ID: 10775128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.